Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sprout Health vs Strut Health

Two GLP-1 desks, one scoreboard. We put Sprout Health and Strut Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 6 · Grade B

Sprout Health

Visit Sprout Health Full brief →
vs
No. 18 · Grade B

Strut Health

Visit Strut Health Full brief →

The verdict

Sprout Health takes this head-to-head.

Sprout Health scores 86 to 84 on our six-factor Brief Score — A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

That doesn't make Strut Health a bad call — it's best for readers who want a needle-free route at the lowest tracked price and are comfortable with a recurring auto-refill. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
84
Supply Reliability
82
82
Transparency
88
86
Access Breadth
92
86
Clinical Oversight
78
82
Track Record
84
84
Sprout HealthBrief Score 86 · 84Strut Health

Price, coverage & the tracker

Sprout HealthStrut Health
Brief Score86/100 (B)84/100 (B)
Semaglutide$149/mo$99/mo lozenge · $149/mo injectable (auto-refill)
Tirzepatide$199/mo$199/mo lozenge · $199/mo injectable (auto-refill)
CoverageNot disclosed49 states (not Alaska)
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

Sprout Health: Compounded $149 semaglutide / $199 tirzepatide held flat this cycle, with a brand-name Wegovy/Zepbound path available on the same account.

Strut Health: Cheapest oral route we track at $99 — but only on auto-refill; the one-off rate runs higher.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.